Global Cervical Fusion Market Overview
Cervical Fusion Market Size was valued at USD 6.15 Billion in 2023. The Global Cervical Fusion industry is projected to grow from USD 6.41 Billion in 2024 to USD 9.02 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.36% during the forecast period (2024 - 2032).
The cervical spinal fusion, also known as arthrodesis, is a surgery to connect bones in the cervical vertebral column of the spine below the neck. In the medical sectors, there are different methods for performing a cervical spinal fusion surgery wherein the most predominant is implanting a bone graft for natural regrowth of the bone. Besides that, the use of artificial grafts such as metal grafts or polymer grafts is also valid technique employed. These synthetic implant grafts are also used to hold the vertebrae together until the growth of a new bone takes place between them.
Based upon our research, we have identified that the macro factors that are driving the global market are the rising frequency of cervical spondylosis among corporate workers and the increasing occurrences of cervical injuries in vehicle accidents. Further, the introduction of biomaterial cervical fusion implants is another factor driving the growth of the cervical fusion market. However, on the other hand worries about post-surgical treatments are serving as a stifling factor for industry growth. Collaborations between large businesses and regional players, on the other hand, boost the market's attractiveness.
Cervical Fusion Market Dynamics
Market Drivers
- Rising prevalence of cervical spondylosis in corporate professionals
Working in the same position over extended periods of time causes strained cervical and One of the conditions that affects professionals the most commonly is cervical spondylosis. IT professionals and computer operators are aware of it. Data from the telemedicine software company Practo indicates that by 2021, online consultation for orthopaedic problems would have grown by 680 percent in India. Doctors saw an increase in consultations for cervical spondylosis during the 2021 shutdown. Long workdays, the work-from-home tendency, and a lack of knowledge about proper posture all had a role in the neck problems. Cervical spondylosis can result in nerve compression, disc degeneration, ligament lesions, and discomfort radiating to the shoulder, arm, and occiput. The issue worsens as a result of the spinal canal narrowing brought on by degeneration.
- Growing cases of cervical injuries in automobile crashes
The increasing number of cervical injuries predominantly owing to phone usage while driving is one of the major reasons for fatal accidents. As per the data published by the U.S. Department of Transportation, 660,000 drivers use cell phones or operate infotainment systems or other electric devices while driving in the US. Additionally, according to the National Highway Traffic Safety Administration (NHTSA), in 2021, 3,142 fatal incidents led to the loss of life due to distracted driving across the US.
Additionally, the NHTSA reported that distracted driving contributed to about 8% of the fatal accidents that occurred in 2021. Critical injuries are frequently caused by such events, which typically affect the neck and spine region. The National Library of Medicine (NLM) reports that in the US, one of the 14 passengers reportedly had neck injuries when being ejected from the car. Due to frontal and side hits, passengers in the front seats were more likely to have serious neck injuries. Among addition, compared to other age groups, the number of neck injuries was higher in the residents between the ages of 16 and 25. These occurrences have increased the market for cervical fusion devices worldwide.
Market Restraints
- Concerns pertaining to the post-surgical procedures
The need for anterior cervical discectomy and fusion (ACDF) treatments has increased recently as a result of an unhealthy lifestyle and long, demanding workdays. The patient who received ACDF surgery later, though, had problems. Insufficient post-operative pain relief was reported by the surgically treated patients, and bone graft healing failure was found. Some more severe post-surgical complications include dysphasia, spinal fluid leak, nerve root damage, spinal cord damage, major blood vessel injury, infection, trachea/esophageal damage, and hematoma. Additionally, the most frequent medical complication seen in patients after surgery is dysphagia. Additionally, it is estimated that one out of every four patients will have Adjacent Segment Disease (ASD), which causes early disc degeneration above and below the fusion and loss of movement across vertebrae. These medical issues have restricted the number of cervical fusion surgeries that may be performed and are expected to impede market expansion throughout the forecast period.
Market Opportunities
- Emergence of biomaterial cervical fusion implants
The rising number of cervical disorders and mishaps has increased global demand for cervical fusion implants. In addition, the demand for biomaterial cervical fusion implants consisting of materials such as cobalt-chromium-molybdenum alloyed with a rough titanium surface coating has increased in recent years. The rough titanium surface coating utilized in the alloy encourages bone development. Similarly, biomaterial cervical fusion implants restore neck mobility to preoperative levels. Furthermore, cobalt, chromium, and molybdenum-coated cervical implants increase bone grafting, range of motion, pain relief, and neck disability index score.
Moreover, other materials used to manufacture cervical fusion implants include silicon nitride, and bioactive glass-ceramic (BGC). Silicon Nitride is specifically used to produce ACDF spacers that aim to restore cervical spine geometry and hold bone grafts throughout the healing course. It is partially radio-opaque, resistant to bacterial adhesion, and offers rapid healing properties. The emergence of biomaterial cervical fusion implants has generated possibilities for the market players and holds huge potential in the cervical fusion market.
Cervical Fusion Market Value Chain Analysis
The value chain analysis for cervical fusion comprises of major components, starting with research and product development followed by manufacturing, distribution, marketing & sales, and ending with post-sales monitoring. The value chain analysis of the global cervical fusion market is very different than the normal industry, and the products are used for treating cervical fusion. In the research & product development phase, new techniques are studied to make the products better and unique.
The key players active in the cervical fusion market are focusing on new product development through research collaborations to study the safety and efficacy of potential cervical fusion products. In this manufacturing process, the product strategies are ready, and the manufacturing process of the product starts. The manufacturing of cervical fusion involves the supply of raw materials and manufacturing products for customers.
Moreover, distribution and sales are a vital part of any industry. In the cervical fusion market, distribution consists of intermediaries, direct selling, and others. It is a critical component of the value chain strategy, which leads to customer satisfaction and competitive advantage. Furthermore, Post-sales monitoring plays a very important role in this market. As cervical fusion is developed for a special purpose, post-sales monitoring is a must.
Cervical Fusion Market Segment Overview
By Fusion Type
- Anterior Interbody Fusion
The anterior interbody fusion is segmented into non-bone interbody cervical fusion, bone interbody cervical fusion, and others. Anterior interbody fusion is a type of spinal fusion in which the spine bones are fused together via an anterior approach. Interbody fusion is a surgical procedure in which the intervertebral disc is removed and replaced with a bone or metal spacer through an anterior approach. In the posterior fusion, the bone graft is inserted on the back side of the vertebrae.
The anterior cervical fusion segment held the majority share in 2021 due to the rising prevalence of degenerative disc disease and growing aging population across the globe. For instance, as per the National Institutes of Health (US), the prevalence of degenerative disc disease is typically proportional to age, with 40% of people aged 40 years having degenerative disc disease, rising to 80% among those aged 80 years or over. Furthermore, the anterior cervical fusion involves the fusing of two or more vertebral columns in order to prevent unwanted spinal disc motion.
During posterior fusion, the bone graft is inserted on the rear side of the vertebrae. Posterior fusion is used in the cervical spine and spine fractures.
The others include Transforaminal lumbar interbody fusion (TLIF), Extreme Lateral Interbody Fusion (XLIF).
By Type
Based on type, the global cervical fusion market has been segmented into metal, polymer, and others. The metal segment dominated the market in 2021 and is projected to be the faster-growing segment of market during the forecast period, 2024-2032.
This is due to the increasing preference for metal implants due to their high resistance to corrosion.Metal materials such as titanium alloys and stainless steel are extensively utilized metal implants in spine surgeries. Many healthcare professionals, including surgeons, doctors, and clinicians have an increasing preference for metal implants due to their high resistance to corrosion.
Moreover, the use of metal implants entails considerably lower costs than polymers. Hence, rising applications of metal material implants for cervical fusion positively impacts the cervical fusion market growth.
Polymer has improved biocompatibility, a high degree of rotation, flexible spine movement, and ease of insertion. Bioresorbable polymer-based materials are currently being employed in spiral interbody fusion surgeries.
Furthermore, bioresorbable polymers offer substantial benefits over metals since they are transitory, much less stiff, and radiolucent. As a result, the increasing use of improved bioresorbable polymer materials for the treatment of different cervical spine illnesses such as degenerative disc disease, cervical spondylosis, and others will drive cervical fusion market expansion over the projection period.
The majority of plates are composed of metal (mostly titanium), although others are made of plastic. Some of the newer plates are constructed of composite materials that disintegrate after fusing. Some plate designs self-compress to aid in spinal fusion.
By Surgery
- Minimally Invasive Spine Surgery
The global cervical fusion market has been bifurcated by surgery into minimally invasive spine surgery and open spine surgery. The minimally invasive spine surgery segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2024-2032. The minimally invasive spine surgery is stabilizing the vertebral bones and spinal joints while also relieving pressure on the spinal nerves. This is commonly caused by disorders such as spinal instability, bone spurs, ruptured discs, scoliosis, or spinal malignancies.
Additionally, in comparison to open spine surgery, minimally invasive surgery is faster, safer, and needs less recovery time. Rising potential benefits such as less blood loss from surgery, lower chance of muscle injury and infection, less postoperative discomfort, and faster recovery from degenerative disc disease, lumbar spinal stenosis, and ruptured disc surgery are likely to drive sector growth throughout the projection period.
The surgeon creates a big incision in the back (about six inches long) and dissects the spinal muscles to draw them away from the bone during traditional open spine surgery. Furthermore, open spine surgery requires lengthy operation durations, general anesthesia, and a lengthy recovery period.
By End Users
Based on end users, the global cervical fusion market has been segmented into orthopedic clinics, multispecialty hospitals, neurology clinics, and others. Orthopedic Clinics held the second largest growing segment in market during the forecast period.
Multispecialty hospitals held the largest segment share in 2021, owing to the rapid adoption of advanced cervical fusion surgery products, and the availability of skilled medical staff. Furthermore, rising government initiatives to enhance healthcare infrastructure, as well as an increase in the number of cervical fusion operations such as minimally invasive spine surgery, are likely to drive the cervical fusion market during the forecast period.
The third fastest growing segment in the cervical fusion market is neurology clinics. Neurology Clinics is committed to researching important clinical connections between neurology and neurosurgery. Because both professions deal with nervous system problems, there are clear areas for collaboration and abundant chances for fruitful synergism.
Specialty Clinics and Ambulatory Surgery Centers are among the other categories. Over the course of the forecast, the other category will expand. Specialty clinics also minimize the hassle of travelling to distant and busy main hospitals, and as a result, they have received positive feedback from patients throughout the years. ASCs are specialized medical facilities that provide outpatient surgical services in addition to that. A patient who has surgery but is not admitted to the hospital is referred to as an outpatient and may leave the facility the same day.
Cervical Fusion Market Regional Analysis
North America
North America accounted for USD 882.93 million in 2021 and is expected to exhibit an 5.06% CAGR during the study period. This is attributed to the growing incidence of spine abnormalities such scoliosis, kyphosis, and lordosis, as well as an ageing population across the region.
Europe
Europe accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the healthcare industry, an ageing population, and an increase in incidence of degenerative disc disease, rheumatoid arthritis, and osteoarthritis.
Asia-Pacific
The Asia-Pacific Cervical Fusion Market is expected to grow at a CAGR of 19.97% from 2024 to 2032. This is due to increased rates of osteoarthritis and degenerative disc disease, the rapidly growing medical tourism industry, and rising healthcare costs
For instance, India is the favored destination for medical travelers due to the availability of surgeons, cutting-edge technology, & cost-effective treatments. On the other hand, Singapore is famous for the presence of well-trained doctors, state-of-the-art facilities, and quality care. As per the data cited in the Medical Tourism Index 2021-22 published by Medical Tourism Association in July 2021, Singapore is ranked at 2nd position, Japan at 3rd, India at 10th, South Korea at 14th, and China at 33rd out of the top 46 international healthcare destinations. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2024–2032.
Competitive Landscape
Key market players are spending a lot of money on R&D to increase their product lines, which will help the cervical fusion market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the cervical fusion market must offer cost-effective items in order to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the global cervical fusion market to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, cervical fusion has provided medicine with some of the most significant benefits. Furthermore, minimally invasive surgeries are being used by surgeons and are highly preferred by patients due to numerous benefits, such as less damage to muscles and soft tissue, less pain after surgery, a shorter hospital stay, and a faster recovery and return to daily activities. These favorable factors are propelling the cervical fusion market forward.
Medtronic Inc. (Ireland) is a global healthcare solutions company committed to improving the lives of people through medical technologies, services, and solutions. With Covidien, the company has accelerated and advanced its ability to create meaningful innovations for hospitals, health systems, and healthcare providers to deliver the best care possible to patients and their families worldwide. The company's businesses majorly fall into four groups, namely the Cardiac and Vascular Group (CVG), the Restorative Therapies Group (RTG), the Diabetes Group, and the Minimally Invasive Therapies Group (MITG). The company operates in over 370 locations across almost 160 countries.
Nuvasive, Inc. (US) is a medical device company that focuses on developing, manufacturing, and selling procedural solutions for spine surgery. The company has a vast spine surgery portfolio such as spine implants, fixation systems, and biologics. It supports spine surgery through a non-profit organization called the NuVasive Spine Foundation, which is dedicated to facilitating service projects that bring life-changing spine surgery to underprivileged communities around the world.
List of companies with HQ
- Medtronic Inc (Ireland)
- Abbott Laboratories (US)
- Stryker Corporation (US)
- DePuy Synthes (US)
- Braun Melsungen AG (Germany)
- NuVasive, Inc (US)
- Zimmer Biomet (US)
- Orthofix (US)
- Globus Medical (US)
Recent Developments
- In September 2021, Medtronic expanded its minimally invasive spine surgery ecosystem with next-generation spinal technologies. Medtronic added three new products to the portfolio: Catalyft PL and PL40, Space-D Access System, and Accelerate Graft Delivery System with Grafton DBF.
- In February 2021, NuVasive, Inc. acquired Simplify Medical, Inc. (US), which develops simplified artificial cervical discs for Cervical Total Disc Replacement (cTDR). The deal was closed at USD150 million. The acquisition enables NuVasive, Inc. to provide an advanced cervical portfolio to leading surgeons worldwide.
- In September 2018, Zimmer Biomet introduced the Mobi-C Cervical Disc for cervical total disc replacement (cTDR). The Mobi-C Cervical Disc is a leading option for cTDR that is designed to restore a healthy disc height and maintain patient range of motion at the operating level, which has helped to boost the cervical fusion market.
Report overview
The study covers the existing short-term and long-term market effects. It helps decision-makers to draught short-term and long-term business plans by region. The report covers major regions in North America, Europe, Asia Pacific, and Rest of the World. The report analyzes market drivers, restraints, opportunities, challenges, Porter's five forces, value chain, and impact of COVID-19 on the market.
Study Objectives
- To provide a comprehensive analysis of the global cervical fusion market and its sub-segments, thereby providing a detailed structure of the industry
- To provide detailed insights into factors driving and restraining the growth of the global market
- To estimate the market size of the global market where 2018 to 2022 would be the historical period, 2023 shall be the base year, and 2024-2032 will be forecast period for the study
- To provide strategic profiling of key companies (manufacturers and distributors) present across the countries, and comprehensively analyze their competitiveness/competitive landscape in this market
- To provide a value chain analysis for the global cervical fusion market.
Market Segmentation:
Global Cervical Fusion Market, by Fusion Type
- Anterior Interbody Fusion
- Anterior Cervical Fusion
- Posterior Fusion
- Others
Global Cervical Fusion Market, by Type
Global Cervical Fusion Market, by Surgery
- Minimally Invasive Spine Surgery
- Open Spine Surgery
Global Cervical Fusion Market, by End User
- Orthopedic Clinics
- Multispecialty Hospitals
- Neurology Clinics
- Others
Global Cervical Fusion Market, by Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Intended Audience
- Cervical fusion suppliers
- Cervical fusion manufacturers
- Research and development (R&D) companies
- Medical research laboratories
- Academic medical institutes and universities
Report Attribute/Metric |
Details |
ย ย Market Size |
ย ย 2032: USD 9.02 Billion |
ย ย CAGR |
ย ย 4.36% |
ย ย Base Year |
ย ย 2023 |
ย ย Forecast Period |
ย ย 2024-2032 |
ย ย Historical Data |
ย ย 2018 & 2022 |
ย ย Forecast Units |
ย ย Value (USD Billion) |
ย ย Report Coverage |
ย ย Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
ย ย Segments Covered |
ย ย Product Type, Operating Platforms, and Region |
ย ย Geographies Covered |
ย ย North America, Europe, Asia Pacific, and Rest of the World |
ย ย Key Vendors |
ย ย Medtronic Inc (Ireland), Abbott Laboratories (US), Stryker Corporation (US), DePuy Synthes (US), B. Braun Melsungen AG (Germany), NuVasive, Inc (US), Zimmer Biomet (US), Orthofix (US), and Globus Medical (US) |
ย ย Key Market Opportunities |
ย ย Emergence of biomaterial cervical fusion implants |
ย ย Key Market Drivers |
ย ย โข Rising prevalence of cervical spondylosis in corporate professionals โข Growing cases of cervical injuries in automobile crashes |
Frequently Asked Questions (FAQ) :
Cervical spinal fusion, also known as arthrodesis, is a surgery to connect bones in the cervical vertebral column of the spine below the neck.
Cervical Fusion Market is expected to exhibit a strong 4.36% CAGR over the forecast period from 2024-2032.
The growing prevalence of osteoarthritis is the major driver for the global Cervical Fusion Cervical Fusion Market.
The Americas dominate the global Cervical Fusion Market, followed by Europe.
Leading players in the Cervical Fusion Market include Medtronic, Stryker, and Biomet, among others